Testosterone ampules, vital for Trans mens' health (if only to stop their bones getting brittle) has been quietly de-listed from the Australian Pharmaceutical Benefits Scheme (PBS), resulting in a quadrupling in price, and ten times the price for those on low incomes with a Health Care card, entitling them to reduced costs on PBS medications.
Apparently it may be because Transsexuality isn't considered to exist as far as the Dept of Health is concerned (there are no drugs on the PBS for treating it), and for non-Trans and non-Intersex men, other alternatives are available. Intersex they're clueless about, and they apparently don't realise what a catastrophic effect this will have on Trans and Intersex mens' health.
This is suspiciously coincidental with the UK National Health Service (NHS) recently putting Testosterone on the "Red List" - meaning it can no longer be prescribed for Trans men (only non-Trans and non-Intersex) by GPs. They have to now obtain the scripts from specialised Gender Clinics - who have no budget for them, so can't provide them. Testosterone has thus been effectively de-listed in the UK too. This follows on from the UK NHS delisting of estrogen implants, which led to the last commercial manufacturer left in the world ceasing to make them last year. That too was based on substitutes being available for everyone except Trans and Intersex women.